PROCYSBI 75 mg Delayed Release Oral Granules
RxNorm 2284516 NDC Crossover

NDC Directory Crossover & Product Mapping

The following National Drug Codes (NDCs) are directly associated with the clinical concept for PROCYSBI 75 mg Delayed Release Oral Granules (RxCUI 2284516). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.

Manufacturer Quick Index

→ Horizon Therapeutics USA, Inc. 4

Horizon Therapeutics USA, Inc.

NDC Product
Human Prescription Drug

Procysbi
NDC 75987-100

Generic Name
Cysteamine Bitartrate
Dosage Form
Capsule, Delayed Release Pellets
Route
Oral
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Procysbi
NDC 75987-101

Generic Name
Cysteamine Bitartrate
Dosage Form
Capsule, Delayed Release Pellets
Route
Oral
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Procysbi
NDC 75987-140

Generic Name
Cysteamine Bitartrate
Dosage Form
Granule, Delayed Release
Route
Oral
Marketing
NDA
Active Listing
NDC Product
Human Prescription Drug

Procysbi
NDC 75987-145

Generic Name
Cysteamine Bitartrate
Dosage Form
Granule, Delayed Release
Route
Oral
Marketing
NDA
Active Listing